Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Learn the key money moves successful people make, from goal setting to conscious spending and informed investing that build lasting wealth.
12,910 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
SpaceX’s public debut sparks a big question for investors: should you ditch Tesla stock in favor of SpaceX? This guid...
The AI boom has put semiconductors in the spotlight. This guide breaks down the AMD vs Intel debate, offering a clear...
Rising component costs revive a pricing debate for Apple. Analysts weigh whether the company should raise prices on i...
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
After four days of tit-for-tat strikes, both sides signaled a pause in the Strait of Hormuz. Markets priced in a mana...
Wealthy investors are tightening tax planning in 2026, leaning on advisers and new strategies to shield gains and boo...
Lucid has dazzled with tech and range, but deep cash burn and production headwinds spark serious questions. Here’s a ...
Is the clock ticking gamestop stock? A practical, not-panic guide for investors weighing whether GameStop can pivot f...
Credo Technology Group has surged about 90% year-to-date, fueling debate on whether the rally can sustain amid new AI...
Many investors hoped the Trumpflation era was fading. This in-depth guide explains why wall street thinks trumpflatio...
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....